Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01463267 · ClinicalTrials.gov registry record · NA

Study of Reminding to Improve Medication Adherence in Heart Failure

A NA study of Heart Failure, sponsored by Kent State University.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT01463267: Completed NA study of Heart Failure, sponsored by Kent State University.

NCT01463267 is a NA study of Heart Failure that has completed, run by Kent State University. The registered enrollment target is 60 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01463267, a NA study of Heart Failure, has completed, sponsored by Kent State University.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study is being done to look at how people manage their heart failure. The investigators are testing two medication reminder systems and the investigators want to know which one people like better. The investigators also want to see if they have any effect on ease of managing medication in individuals with heart failure.

Primary Outcome

Patient ratings of their satisfaction with the device, ease of use, and other impressions. A survey was created for this study to assess individuals' evaluations of the device to which they were randomized (see Appendix 1). At the final study session, participants completed the questionnaire about their preference for the device they were assigned. The 14 items were summed into a total score reflecting their ultimate appraisal for the device. The range of possible scores was 14-70. A higher scor

Conditions Studied

Interventions

  • DEVICE iPhone or pillbox
  • BEHAVIORAL Non-reminding

Study Locations (1)

Ohio

  • Akron City Hospital - Akron

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2010-11
Est. Completion 2012-09
Phase NA
Kent State University

19 total trials

What the finished NCT01463267 record still lists

NCT01463267 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which iPhone or pillbox is the first listed.

NCT01463267 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT01463267 about?

NCT01463267 is a clinical study titled "Study of Reminding to Improve Medication Adherence in Heart Failure". This study is being done to look at how people manage their heart failure. The investigators are testing two medication reminder systems and the investigators want to know which one people like better. The investigators also want to see if they have any effect on ease of managing medication in indiv...

What is the current status of trial NCT01463267?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2010-11. Estimated completion is 2012-09.

What conditions does trial NCT01463267 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT01463267?

The interventions under investigation include: iPhone or pillbox (DEVICE), Non-reminding (BEHAVIORAL).

Who is sponsoring clinical trial NCT01463267?

This trial is sponsored by Kent State University, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01463267 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01463267's enrollment target sits among peer trials

60 254th of 397 higher than 131 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01463267, the US trial registry maintained by the National Library of Medicine. NCT01463267 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.